US 12,076,414 B2
Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers
Elizabeth Bruning, Skillman, NJ (US); Anthony Robert Geonnotti, III, Skillman, NJ (US); Euen Thomas Ekman-Gunn, Skillman, NJ (US); Russel Walters, Skillman, NJ (US); Alpana Oak, Skillman, NJ (US); Frank C. Sun, Skillman, NJ (US); Kimberly Capone, Skillman, NJ (US); and Frank J. Kirchner, Skillman, NJ (US)
Assigned to Johnson & Johnson Consumer Inc., Skillman, NJ (US)
Filed by Johnson & Johnson Consumer Inc., Skillman, NJ (US)
Filed on Apr. 23, 2020, as Appl. No. 16/856,893.
Prior Publication US 2021/0330806 A1, Oct. 28, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 47/69 (2017.01); A61K 9/06 (2006.01); A61K 47/32 (2006.01); C12N 7/00 (2006.01)
CPC A61K 47/6903 (2017.08) [A61K 47/32 (2013.01); C12N 7/00 (2013.01); A61K 9/06 (2013.01)] 16 Claims
 
1. A method of inhibiting entry of enveloped viruses into cells comprising contacting said viruses with an anti-viral composition comprising at least one high molecular weight hydrophobically modified polymer in an amount effective to inhibit entry of viruses into cells, wherein said anti-viral composition is free of surfactant having an HLB of greater than 12, wherein said high molecular weight hydrophobically modified polymer is polyacrylate-33.